Travere Therapeutics, Inc. · NASDAQ:TVTX
Vanguard Capital Management LLC reported a 5.09% stake in Travere Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.09% stake in Travere Therapeutics, Inc., 4,699,424 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.09%
- Shares
- 4,699,424
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.09% | 4,699,424 |